Strong HA - Search Results

1

Pharmacokinetics of intravenous dantrolene in children.

Lerman J, McLeod ME, Strong HA. Lerman J, et al. Among authors: strong ha. Anesthesiology. 1989 Apr;70(4):625-9. doi: 10.1097/00000542-198904000-00013. Anesthesiology. 1989. PMID: 2929999

2

Pharmacokinetics of lidocaine in children with congenital heart disease.

Burrows FA, Lerman J, LeDez KM, Strong HA. Burrows FA, et al. Among authors: strong ha. Can J Anaesth. 1991 Mar;38(2):196-200. doi: 10.1007/BF03008144. Can J Anaesth. 1991. PMID: 2021989

3

Alpha 1-acid glycoprotein and the binding of lidocaine in children with congenital heart disease.

Burrows FA, Lerman J, LeDez KM, Strong HA. Burrows FA, et al. Among authors: strong ha. Can J Anaesth. 1990 Nov;37(8):883-8. doi: 10.1007/BF03006625. Can J Anaesth. 1990. PMID: 1701361

4

Effects of age on the serum concentration of alpha 1-acid glycoprotein and the binding of lidocaine in pediatric patients.

Lerman J, Strong HA, LeDez KM, Swartz J, Rieder MJ, Burrows FA. Lerman J, et al. Among authors: strong ha. Clin Pharmacol Ther. 1989 Aug;46(2):219-25. doi: 10.1038/clpt.1989.129. Clin Pharmacol Ther. 1989. PMID: 2758731

5

Highly sensitive determination of cimetidine and its metabolites in serum and urine by high-performance liquid chromatography.

Strong HA, Spino M. Strong HA, et al. J Chromatogr. 1987 Nov 27;422:301-8. doi: 10.1016/0378-4347(87)80467-x. J Chromatogr. 1987. PMID: 3437018 No abstract available.

6

Effect of grapefruit juice and naringin on nisoldipine pharmacokinetics.

Bailey DG, Arnold JM, Strong HA, Munoz C, Spence JD. Bailey DG, et al. Among authors: strong ha. Clin Pharmacol Ther. 1993 Dec;54(6):589-94. doi: 10.1038/clpt.1993.195. Clin Pharmacol Ther. 1993. PMID: 8275614 Clinical Trial.

7

Once- vs. twice-daily nitrendipine in the treatment of mild to moderate hypertension, Canadian Nitrendipine Study Group.

Bolli P, Cobby J, Handa SP, Laplante LE, Mukherjee J, Rabin EZ, Strong HA, Wright JM. Bolli P, et al. Among authors: strong ha. J Cardiovasc Pharmacol. 1991;17 Suppl 2:S182-5. doi: 10.1097/00005344-199117002-00047. J Cardiovasc Pharmacol. 1991. PMID: 1715478 Clinical Trial.

8

Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3.

Bressler NM, Arnold J, Benchaboune M, Blumenkranz MS, Fish GE, Gragoudas ES, Lewis H, Schmidt-Erfurth U, Slakter JS, Bressler SB, Manos K, Hao Y, Hayes L, Koester J, Reaves A, Strong HA; Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Bressler NM, et al. Among authors: strong ha. Arch Ophthalmol. 2002 Nov;120(11):1443-54. doi: 10.1001/archopht.120.11.1443. Arch Ophthalmol. 2002. PMID: 12427056 Clinical Trial.

9

Efficacy of once daily nitrendipine in mild hypertension: comparison with placebo.

Fodor JG, Chockalingam A, Cifkova R, Strong HA, Cobby J, Mukherjee J. Fodor JG, et al. Among authors: strong ha. Can J Cardiol. 1991 Jun;7(5):223-8. Can J Cardiol. 1991. PMID: 1860094 Clinical Trial.

10

Effectiveness and tolerability of once versus twice daily nitrendipine in the treatment of mild to moderate hypertension. The Canadian Nitrendipine Study Group.

Bolli P, Cobby J, Handa SP, LaPlante LE, Mukherjee J, Rabin EZ, Strong HA, Wright JM. Bolli P, et al. Among authors: strong ha. Can J Cardiol. 1991 Mar;7(2):59-64. Can J Cardiol. 1991. PMID: 2049684 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

34 results

Search Page

Filters